Last update May 29, 2022
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Cinitapride in other languages or writings:
Cinitapride belongs to this group or family:
Main tradenames from several countries containing Cinitapride in its composition:
|T½||3 - 5||hours|
Write us at firstname.lastname@example.org
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
It is a substituted Benzamide drug that is similar to Cisapride. It is used in functional dyspepsia. Oral administration three times a day. (Du 2014, Baqai 2013
At latest update no published data on excretion into breast milk were found.
Drug that is poorly documented in the scientific literature. It seems to be lacking of side effects (QT-interval prolongation, cardiac arrhythmias) that led to the withdrawal of Cisapride. (Castro 2011, Mearín 2010, Portincasa 2009, Robert 2007)
Until more published information about this drug regarding breastfeeding appears, it may be preferable a known and safer alternative, especially during the neonatal period and in cases of prematurity.